Roche 1H Revenue: 30.7 billion CHF (+5%) Net Earnings: 8.2 billion CHF (-3%) Comments: Pharmaceutical Division sales were 21.7 billion CHF down 3. While sales in the first quarter were still strongly affected by COVID-19 (-9%), the second quarter showed signs of recovery in some regions (+4%). The ongoing impact from biosimilars, particularly in the U.S., resulted in a sales decrease of CHF 2.8 billion, however newly launched medicines (+30%) helped offset continued impact from biosimilars. I...